Pfizer Acquires Emergen-C Maker

February 29, 2012

While the deal’s financial terms were not disclosed, the companies said that it will help expand Emergen-C distribution.

Drug firm Pfizer has acquired Alacer Corp., the maker of the Emergen-C line of effervescent vitamin C supplements. According to the companies, Emergen-C is the largest-selling vitamin C brand in the United States. Alacer, which had been privately held, produces nearly 500 million packets of product annually.

While the deal’s financial terms were not disclosed, the companies said that it will help expand Emergen-C distribution. “Emergen-C products add to and greatly complement our market-leading dietary supplement portfolio,” added Paul Sturman, president of Pfizer Consumer Healthcare, in a press release.

Related Content:

Immune Support